BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28252462)

  • 1. The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review.
    Kunzmann AT; Graham S; McShane CM; Doyle J; Tommasino M; Johnston B; Jamison J; James JA; McManus D; Anderson LA
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):817-825. PubMed ID: 28252462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
    Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
    Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.
    Antonsson A; Knight L; Whiteman DC;
    Cancer Epidemiol; 2016 Apr; 41():96-8. PubMed ID: 26895084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma.
    Parameshwaran K; Sharma P; Rajendra S; Stelzer-Braid S; Xuan W; Rawlinson WD
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31313804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance.
    Iyer A; Rajendran V; Adamson CS; Peng Z; Cooper K; Evans MF
    J Clin Virol; 2011 Mar; 50(3):205-8. PubMed ID: 21169053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event.
    Rai N; Jenkins GJ; McAdam E; Hibbitts SJ; Fiander AN; Powell NG
    J Clin Virol; 2008 Oct; 43(2):250-2. PubMed ID: 18718811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for esophageal cancer: emphasis on infectious agents.
    El-Zimaity H; Di Pilato V; Novella Ringressi M; Brcic I; Rajendra S; Langer R; Dislich B; Tripathi M; Guindi M; Riddell R
    Ann N Y Acad Sci; 2018 Dec; 1434(1):319-332. PubMed ID: 29851130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett's esophagus: a systematic review and meta-analysis.
    Chandrasekar VT; Hamade N; Desai M; Rai T; Gorrepati VS; Jegadeesan R; Sathyamurthy A; Sharma P
    Endoscopy; 2019 Jul; 51(7):665-672. PubMed ID: 30939618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and the risk of Barrett's esophagus.
    El-Serag HB; Hollier JM; Gravitt P; Alsarraj A; Younes M
    Dis Esophagus; 2013 Jul; 26(5):517-21. PubMed ID: 22891654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
    Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P
    Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus in esophageal and gastroesophageal junction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience from Turkey and review of literature.
    Türkay DÖ; Vural Ç; Sayan M; Gürbüz Y
    Pathol Res Pract; 2016 Feb; 212(2):77-82. PubMed ID: 26608416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
    Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
    Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
    Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
    Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.